Child Development Disorders, Pervasive Clinical Trial
Official title:
Using Mobile Technology to Reduce Stereotypy in Children With Autism Spectrum Disorders
Verified date | September 2019 |
Source | Université de Montréal |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Nearly all children with autism spectrum disorders engage in non-functional repetitive vocal and motor behaviours commonly referred to as stereotypy. These repetitive behaviours may considerably interfere with the child's daily functioning, learning, and social inclusion. As such, stereotypy generally has a negative impact on the child and family's health and quality of life. Several behavioural interventions have been developed to reduce engagement in stereotypy in children with autism spectrum disorders, but the limited number of specialists available, the long waiting lists associated with public health services in Canada, and the high costs of private services have considerably restricted accessibility. One potential solution to the limited availability and high costs of services is using a mobile application to recommend, teach, and monitor interventions designed to reduce engagement in stereotypy. To this end, the purpose of the study is to evaluate the effects of the iSTIM (i.e., individualized Stereotypy Treatment Integrated Modules), a mobile application designed to assist parents in reducing stereotypy in children with autism spectrum disorders. Specifically, we will assess whether the iSTIM correctly estimates the frequency or duration of stereotypy, offers suggestions consistent with recommended clinical practices, effectively reduces engagement in stereotypy, and is socially acceptable, safe, and easy to use for parents of children with autism spectrum disorders. The results of the study will allow us to determine whether the mobile application may be used to treat this core symptom in children with autism spectrum disorders, which could potentially reduce waiting times and costs of providing health services to this population. By reducing engagement in stereotypy, the iSTIM may also promote and facilitate the social participation as well as improve the quality of life and health of children with autism spectrum disorders and their families.
Status | Completed |
Enrollment | 39 |
Est. completion date | February 2019 |
Est. primary completion date | February 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A to 12 Years |
Eligibility |
Inclusion Criteria: - Clinical diagnosis of autism spectrum disorders - Must engage in at least one form of stereotypy Exclusion Criteria: - Stereotypy occurs less than 12 times per hour (or less than 20% of time) - The form of stereotypy is potentially dangerous for the person (e.g., head banging, self-biting) - The form of stereotypy is maintained by social consequences (e.g., attention, task avoidance) |
Country | Name | City | State |
---|---|---|---|
Canada | Monarch House | Mississauga | Ontario |
Canada | CRDITED de Montréal | Montreal | Quebec |
Canada | Gold Centre | Montreal | Quebec |
Lead Sponsor | Collaborator |
---|---|
Université de Montréal |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Frequency and duration of stereotypy | Direct observation of the frequency and duration of stereotypy during 10- to 60-minute sessions | 2 to 4 times per week over 8 to 16 weeks | |
Secondary | Social validity score | The user responds to a social validity questionnaire | Immediately following the end of the intervention (i.e., after 8 to 16 weeks) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03222375 -
SQUEDâ„¢ Series 28.1 Home-use and Treatment of Autowave Reverberator of Autism
|
N/A | |
Completed |
NCT01233414 -
Randomized Trial of Parent Training for Young Children With Autism
|
N/A | |
Completed |
NCT00926471 -
Social Skills and Anxiety Reduction Treatment for Children and Adolescents With Autism Spectrum Disorders
|
Phase 1 | |
Withdrawn |
NCT00376194 -
Mercury Chelation to Treat Autism
|
Phase 2 | |
Completed |
NCT02153203 -
Using the Prevent-Teach-Reinforce Model to Reduce Problem Behaviors in Children With Autism Spectrum Disorders
|
N/A | |
Completed |
NCT02301195 -
Trial of Therapeutic Horseback Riding in Children and Adolescents With Autism Spectrum Disorder
|
N/A | |
Completed |
NCT00453180 -
A Study of Oral N-Acetylcysteine in Children With Autism Spectrum Disorders
|
Phase 2 | |
Completed |
NCT04475848 -
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of RO6953958 in Healthy Participants
|
Phase 1 | |
Terminated |
NCT01517126 -
Assessing Suicide Risk in Adolescents With Developmental Delays
|
||
Completed |
NCT00080145 -
RUPP PI PDD: Drug and Behavioral Therapy for Children With Pervasive Developmental Disorders
|
N/A | |
Completed |
NCT00166595 -
Pharmacogenetics of Risperidone in Children With Pervasive Developmental Disorder (PDD)
|
Phase 1/Phase 2 | |
Completed |
NCT01731119 -
Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
|
Phase 2 | |
Completed |
NCT00147394 -
Risperidone Pharmacokinetics in Children With Pervasive Developmental Disorder (PDD)
|
Phase 1 | |
Completed |
NCT01921244 -
Shared Decision Making to Improve Care and Outcomes for Children With Autism
|
N/A | |
Completed |
NCT05688319 -
Effect of Problem-Solving Training
|
N/A | |
Terminated |
NCT00445471 -
A Prospective Study Comparing the Mifne Approach of Treating Childhood Autism With Routine Standard Treatment
|
N/A | |
Active, not recruiting |
NCT00110708 -
Safety and Efficacy Study in the Treatment of Intestinal Problems Associated With Autism
|
Phase 2 |